David R Moller
Overview
Explore the profile of David R Moller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharp M, Psoter K, Mustafa A, Chen E, Lin N, Mathai S, et al.
Thorax
. 2024 Jun;
79(11):1033-1039.
PMID: 38906696
Introduction: Given the heterogeneity of sarcoidosis, predicting disease course of patients remains a challenge. Our aim was to determine whether the 3-year change in pulmonary function differed between pulmonary function...
2.
Casanova N, Camp S, Gonzalez-Garay M, Batai K, Garman L, Montgomery C, et al.
Eur J Respir Med
. 2024 Feb;
5(1):359-371.
PMID: 38390497
Background: A limited pool of SNPs are linked to the development and severity of sarcoidosis, a systemic granulomatous inflammatory disease. By integrating genome-wide association studies (GWAS) data and expression quantitative...
3.
Weeratunga P, Moller D, Ho L
J Clin Invest
. 2024 Jan;
134(1).
PMID: 38165044
Sarcoidosis is a complex immune-mediated disease characterized by clusters of immune cells called granulomas. Despite major steps in understanding the cause of this disease, many questions remain. In this Review,...
4.
Weeratunga P, Moller D, Ho L
Eur Respir Rev
. 2022 Dec;
31(166).
PMID: 36543347
Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted...
5.
Sharp M, Psoter K, Balasubramanian A, Pulapaka A, Chen E, Brown S, et al.
Ann Am Thorac Soc
. 2022 Aug;
20(1):30-37.
PMID: 35926103
Historically, sarcoidosis was described as a restrictive lung disease, but several alternative phenotypes of pulmonary function have been observed. Pulmonary function phenotypes in sarcoidosis may represent different clinical and/or molecular...
6.
Vukmirovic M, Yan X, Gibson K, Gulati M, Schupp J, DeIuliis G, et al.
Eur Respir J
. 2021 Jun;
58(6).
PMID: 34083402
Background: Sarcoidosis is a multisystem granulomatous disease of unknown origin with a variable and often unpredictable course and pattern of organ involvement. In this study we sought to identify specific...
7.
Murphy O, Salazar-Camelo A, Jimenez J, Barreras P, Reyes M, Garcia M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2020 Apr;
7(4).
PMID: 32269072
Objective: To determine the characteristic clinical and spinal MRI phenotypes of sarcoidosis-associated myelopathy (SAM), we analyzed a large cohort of patients with this disorder. Methods: Patients diagnosed with SAM at...
8.
Sharp M, Brown T, Chen E, Rand C, Moller D, Eakin M
Chest
. 2020 Feb;
158(1):226-233.
PMID: 32032588
Background: Sarcoidosis, one of the most common interstitial lung diseases, has significant health disparities. Approximately 50% of individuals affected with sarcoidosis will undergo spontaneous remission, but those who do not...
9.
Sharp M, Brown T, Chen E, Rand C, Moller D, Eakin M
BMJ Open Respir Res
. 2019 Nov;
6(1):e000467.
PMID: 31673367
Introduction: Sarcoidosis is a multisystem granulomatous inflammatory disorder. Sarcoidosis is associated with significant morbidity and rising healthcare utilisation. Patients with sarcoidosis report higher psychological symptoms than the general population. We...
10.
Grunewald J, Grutters J, Arkema E, Saketkoo L, Moller D, Muller-Quernheim J
Nat Rev Dis Primers
. 2019 Jul;
5(1):49.
PMID: 31311930
An amendment to this paper has been published and can be accessed via a link at the top of the paper.